Daiwa Securities Group
IPSC icon

Daiwa Securities Group’s Century Therapeutics IPSC Stock Holding History

Daiwa Securities Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-159
Closed – – 1356
2023
Q3 		$0 Hold
159
– – ﹤0.01% 1312
2023
Q2 		$1K Hold
159
– – ﹤0.01% 1279
2023
Q1 		$1K Hold
159
– – ﹤0.01% 1257
2022
Q4 		$1K Hold
159
– – ﹤0.01% 1275
2022
Q3 		$2K Hold
159
– – ﹤0.01% 1232
2022
Q2 		$1K Hold
159
– – ﹤0.01% 1292
2022
Q1 		$2K Hold
159
– – ﹤0.01% 1255
2021
Q4 		$3K Buy
+159
New +$2.99K ﹤0.01% 1246

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Daiwa Securities Group's IPSC Position: Q4 2023 in Review

Daiwa Securities Group sold out of Century Therapeutics (IPSC) in Q4 2023, closing a stake of 159 shares.

Daiwa Securities Group first reported a position in IPSC in Q4 2021 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 63 funds tracked by Wall St. Rank hold IPSC as of Q4 2023.

  • Daiwa Securities Group reported no remaining Century Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 159 Century Therapeutics shares in Q4 2023.
  • Daiwa Securities Group first reported a position in Century Therapeutics in Q4 2021 and held it in 8 quarters.
  • Daiwa Securities Group's Century Therapeutics position peaked at $3K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Century Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.